These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 1849626)
1. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Kurman RJ; Malkasian GD; Sedlis A; Solomon D Obstet Gynecol; 1991 May; 77(5):779-82. PubMed ID: 1849626 [TBL] [Abstract][Full Text] [Related]
2. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Syrjänen K; Kataja V; Yliskoski M; Chang F; Syrjänen S; Saarikoski S Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):675-82. PubMed ID: 1314359 [TBL] [Abstract][Full Text] [Related]
3. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745 [TBL] [Abstract][Full Text] [Related]
4. Polymerase chain reaction-assisted evaluation of low and high grade squamous intraepithelial lesion cytology and reappraisal of the Bethesda System. Kühler-Obbarius C; Milde-Langosch K; Löning T; Stegner HE Acta Cytol; 1994; 38(5):681-6. PubMed ID: 8091897 [TBL] [Abstract][Full Text] [Related]
5. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136 [TBL] [Abstract][Full Text] [Related]
6. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Liao SY; Stanbridge EJ Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360 [TBL] [Abstract][Full Text] [Related]
7. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear. Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525 [TBL] [Abstract][Full Text] [Related]
8. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria. Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461 [TBL] [Abstract][Full Text] [Related]
9. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression? Sherman ME; Kelly D Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939 [TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion. Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557 [TBL] [Abstract][Full Text] [Related]
11. [Detection of various papilloma virus types in cytologic smears of precancerous conditions and cancers of the uterine cervix]. Wagner D; de Villiers EM; Gissmann L Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):226-31. PubMed ID: 2989076 [TBL] [Abstract][Full Text] [Related]
12. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681 [TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Negrini BP; Schiffman MH; Kurman RJ; Barnes W; Lannom L; Malley K; Brinton LA; Delgado G; Jones S; Tchabo JG Cancer Res; 1990 Aug; 50(15):4670-5. PubMed ID: 2164444 [TBL] [Abstract][Full Text] [Related]
14. The Bethesda classification for squamous intraepithelial lesions: histologic, cytologic, and viral correlates. Tabbara S; Saleh AD; Andersen WA; Barber SR; Taylor PT; Crum CP Obstet Gynecol; 1992 Mar; 79(3):338-46. PubMed ID: 1738511 [TBL] [Abstract][Full Text] [Related]
15. [The Papanicolaou classification in the Bethesda system (National Cancer Institute, Bethesda, Maryland)]. Broso PR; Buffetti G Minerva Ginecol; 1993 Nov; 45(11):557-63. PubMed ID: 8121604 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the atypical cytologic smear. Validity of the 1991 Bethesda System. Widra EA; Dookhan D; Jordan A; McCue P; Bibbo M; Dunton CJ J Reprod Med; 1994 Sep; 39(9):682-4. PubMed ID: 7807479 [TBL] [Abstract][Full Text] [Related]
17. The terminology of pre-invasive cervical lesions in the UK cervical screening programme. Herrington CS Cytopathology; 2015 Dec; 26(6):346-50. PubMed ID: 26767601 [TBL] [Abstract][Full Text] [Related]
18. Is it possible to define a better ASCUS class in cervicovaginal screening? A review of 187 cases. Guerrini L; Sama D; Visani M; Cotignoli T; Sintoni C; Maioli P; Lanzanova G; Schincaglia P Acta Cytol; 2001; 45(4):532-6. PubMed ID: 11480714 [TBL] [Abstract][Full Text] [Related]
19. Is the HSIL subclassification cytologically real and clinically justified? Milicić-Juhas V; Pajtler M Coll Antropol; 2010 Jun; 34(2):395-400. PubMed ID: 20698108 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and survey of abnormal/atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: a retrospective study. Giudice A; Rizzo M; Rossi RT; Bonaffini O; Buda CA; Pettineo G Anticancer Res; 2000; 20(2B):1195-9. PubMed ID: 10810421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]